Search Results
Results found for "Zhan-Guo Gao"
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
C5aR2 is a nonclassical GPCR that tailors immune cell activity potentially through β-arrestins rather than
- Delineation of GPR15 receptor-mediated Gα protein signaling profile in recombinant mammalian cell
The results show that the GPR15 receptor preferentially couples to Gi/o rather than other pathways in
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
therapeutic benefit Where not to target to avoid adverse effects Why GPCR Imaging Tools Matter More Than
- Comparative studies of AlphaFold, RoseTTAFold and Modeller: a case study involving the use of...
program's top-scored structure, Modeller had the smallest average modeling RMSD of 2.17 Å, which is better than
- Design and validation of recombinant protein standards for quantitative Western blot analysis of...
density obtained by quantitative Western blot were of the same order of magnitude but slightly higher than
- AlphaFold’s Breakthrough in GPCR Research: Revolutionizing Discovery, Yet Awaiting Experimental Proof
AlphaFold2 outperformed homology models, achieving a 60% hit rate for compounds targeting TAAR1, more than
- GPCR Happy Hour – Boston, Sept 2025
GPCR Happy Hour is more than a social event.
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
was highly expressed in breast cancers, and patients harboring altered GASP1 showed a worse prognosis than
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
Rather than chasing potency alone, this session equips drug hunters with system-level thinking: how
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
Time” Now Only in Terry’s Corner Why Terry’s Corner In a world where drug discovery is evolving faster than
- How Fast Does a Drug Work?
Why Faster, Smarter Decisions Require More Than Kd In drug discovery today, the clock is always ticking
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
With Premium, you move faster, smarter, and more confidently than peers relying on scattered signals.
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
Beyond the Curve: Questions This Lesson Helps You Answer This lesson pushes you to go deeper than surface-level
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
Cryptic Sites, Longer Onset: Why Some Drugs Work Differently in Cells Than in Assays One of the most
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
Intracellular Drugs” Now Only in Terry’s Corner Why Terry’s Corner In a world where GPCR science moves faster than
- Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic ...
It is predicted that more than 50 GPCRs are expressed in the liver.
- Platelets in the NETworks interweaving inflammation and thrombosis
In light of the current COVID-19 pandemic, the topic of immunothrombosis has become more relevant than
- Do You Believe AI Could Accelerate Drug Discovery?
Of 161 molecules tested, 42 substituted more than 50% of [³H]-LSD at 10 μM, achieving a 26% hit rate.
- Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled ...
Because there are many more GPCRs than effectors, mutations in different receptors could perturb signaling
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
of GPCR activation has always been a challenge because G protein activation in cells occurs in less than
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Key next questions: Why do some patients respond better than others?
- How Schild Analysis Protects Your Conclusions in GPCR Research
Visualizing GLP-1 & GIP Receptors in Islets and Brain Understanding incretin biology depends on more than
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
These receptors have much larger binding pockets than the majority of GPCRs that have been successfully ’ interaction ensures that all molecules in the library are specific for the target receptor rather than either G protein signaling or arrestin signaling, and superagonists with signaling activity higher than conjugate exhibited poor selectivity for CCR5-expressing cells and was less effective at killing cells than Orion’s CCR2 antagonist analog (OB-004), discovered in only 6 months, is considerably more potent than
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
At early stages, breadth matters more than precision. Cast a wide net. Follow anomalies.
- Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...
internalize both receptors whereas pasireotide promoted robust receptor internalization at shorter times than
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
The GPCR Precision Blueprint is more than a concept.
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
method can’t resolve subtle potency differences, the team prefers to acknowledge that limitation rather than
- The Five Traps of Ignoring Kinetics
That’s your signal: kinetics are moving faster than your tools can measure.
- Curve Shifts Don’t Lie, But Your Eyes Might
against standards and across methods Trust that your conclusions reflect reality, not bias This is more than
- Understanding the Journey: Catherine Demery's Path to Addiction Science
She found herself drawn toward the science behind the drugs, rather than their clinical application.




















